Market Overview

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN)

128.43 +0.73 (0.57%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2019
Pre-Market
EPS:
REV:
2.07
1.045B



Q1 2019
Pre-Market
EPS:
REV:
1.68
930.9M



Q4 2018
Pre-Market
EPS:
REV:
1.48
909.7M



Q3 2018
Pre-Market
EPS:
REV:
1.44
859M



Q2 2018
Pre-Market
EPS:
REV:
1.56
912M
1.7
977.89M
2.07
1.045B
21.76%
6.86%
Q1 2018
Pre-Market
EPS:
REV:
1.38
870M
1.49
922.55M
1.68
930.9M
12.75%
0.91%
Q4 2017
Pre-Market
EPS:
REV:
1.26
831M
1.28
880.65M
1.48
909.7M
15.63%
3.3%
Q3 2017
Pre-Market
EPS:
REV:
1.23
799.106M
1.33
864.53M
1.44
859M
8.27%
-0.64%
Q2 2017
Pre-Market
EPS:
REV:
1.13
753.116M
1.25
845.28M
1.56
912M
24.8%
7.89%
Q1 2017
Pre-Market
EPS:
REV:
1.11
701.038M
1.24
824.68M
1.38
870M
11.29%
5.5%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!